Indica, sativa and hybrid labels don't predict much, a 28-study review concludes

A systematic review in the Journal of Cannabis Research pulled together 28 peer-reviewed studies from 2011 to 2026 to ask a simple question: do the indica, sativa and hybrid labels tell you anything reliable? The evidence base was 12 analyses of plants, product databases and chemistry, 15 human studies and one animal study.

On chemistry, the answer was mostly no. A Washington State analysis of more than 97,000 flower test records found hybrids carried higher THC than either indica or sativa, with no real difference between those two. A California look at 1,426 dispensary products found no meaningful THC gap among the three. Genetic studies did not show the labels lining up with distinct groups, which the authors tie to crossbreeding and loose naming. Some terpenes leaned toward one label or another, but inconsistently.

On effects, human studies of pain, anxiety, sleep, nausea and mood mostly saw no difference by label. A few isolated findings did not replicate. The authors also flag that expectation can shape what people report.

The caveats are real: observational data, uneven testing methods, overlapping datasets and too much variation to run a statistical meta-analysis. For shops and brands, the practical read is to lead with tested cannabinoids, terpene data, form and dose, and treat label-based effect promises with suspicion. The authors also call terpene-specific prescribing preliminary.